Antimalarial drug discovery - The path towards eradication

Parasitology

Volumn 141, Issue 1, 2014, Pages 128-139

  Burrows, Jeremy N ^a   Burlot, Emilie ^a   Campo, Brice ^a   Cherbuin, Stephanie ^a   Jeanneret, Sarah ^a   Leroy, Didier ^a   Spangenberg, Thomas ^a   Waterson, David ^a   Wells, Timothy N C ^a   Willis, Paul ^a  

^a ICC   (Switzerland)

Author keywords

eradication; malaria; MMV; Plasmodium; Target Product Profile

Indexed keywords

ANTIMALARIAL AGENT; DSM 265; ENDOPEROXIDE; GNF 156; NITD 609; OZ 439; P 218; UNCLASSIFIED DRUG; DRUG COMBINATION;

ARTICLE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMMUNITY; DISEASE COURSE; DISEASE TRANSMISSION; HUMAN; MALARIA; MALARIA CONTROL; MEDICAL RESEARCH; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; CLINICAL TRIAL (TOPIC); DISEASE ERADICATION; DRUG COMBINATION; DRUG DESIGN; DRUG DEVELOPMENT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; LIFE CYCLE STAGE; METABOLISM; PARASITOLOGY; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANTIMALARIALS; CLINICAL TRIALS AS TOPIC; DISEASE ERADICATION; DRUG COMBINATIONS; DRUG DESIGN; DRUG DISCOVERY; HUMANS; LIFE CYCLE STAGES; MALARIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84891838984     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182013000826     Document Type: Article

References (51)

1. Alonso, P. L., Brown, G., Arevalo-Herrera, M., Binka, F., Chitnis, C., Collins, F., Doumbo, O. K., Greenwood, B., Hall, B. F., Levine, M. M., Mendis, K., Newman, R. D., Plowe, C. V., Rodriguez, M. H., Sinden, R., Slutsker, L. and Tanner, M. (2011). A research agenda to underpin malaria eradication. PLoS Medicine 8, e1000406
2. Angulo-Barturen, I., Jimenez-Diaz, M. B., Mulet, T., Rullas, J., Herreros, E., Ferrer, S., Jimenez, E., Mendoza, A., Regadera, J., Rosenthal, P. J., Bathurst, I., Pompliano, D. L., Gomez de lasHeras, F. and Gargallo-Viola, D. (2008). A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS ONE 3, e2252
3. Anthony, M. P., Burrows, J. N., Duparc, S., Moehrle, J. and Wells, T. N. C. (2012). The global pipeline of new medicines for the control and elimination of malaria. Malaria Journal 11, 316
4. Baird, J K. and Rieckmann, K.H. (2003). Can primaquine therapy for vivax malaria be improved? Trends in Parasitology 19, 115-120
5. Bousema, T., Okell, L., Shekalaghe, S., Griffin, J. T., Omar, S., Sawa, P., Sutherland, C., Sauerwein, R., Ghani, A. C. and Drakeley, C. (2010). Revisiting the circulation time of Plasmodium falciparum gametocytes: Molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malaria Journal 9, 136
6. Burrows, J. N., Chibale, K. and Wells, T. N. C. (2011b). The state of the art in anti-malarial drug discovery and development. Current Topics in Medicinal Chemistry 11, 1226-1254
7. Burrows, J. N., Hooft, R., Möhrle, J., Oeuvray, C. and Wells, T. N. C. (2013). Designing the next generation of medicines for malaria control and eradication. Malaria Journal in press
8. Burrows, J. N., Leroy, D., Lotharius, J. and Waterson, D. (2011a). Challenges in antimalarial drug discovery. Future Medicinal Chemistry 3, 1401
9. Burrows, J. N. and Waterson, D. (2011). Discovering new medicines to control and eradicate malaria. Topics in Medicinal Chemistry 7, 125-180
10. Charman, S. A., Arbe-Barnes, S., Bathurst, I. C., Brun, R., Campbell, M., Charman, W. N., Chiu, F. C., Chollet, J., Craft, J. C., Creek, D. J., Dong, Y., Matile, H., Maurer, M., Morizzi, J., Nguyen, T., Papastogiannidis, P., Scheurer, C., Shackleford, D. M., Sriraghavan, K., Stingelin, L., Tang, Y., Urwyler, H., Wang, X., White, K. L., Wittlin, S., Zhou, L. and Vennerstrom, J. L. (2011). Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proceedings of the National Academy of Science, USA 108, 4400-4405
11. Chico, R. M., Pittrof, R., Greenwood, B. and Chandramohan, D. (2008). Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy. Malaria Journal 7, 255
12. Coteron, J. M., Marco, M., Esquivias, J., Deng, X., White, K. L., White, J., Koltun, M., El Mazouni, F., Kokkonda, S., Katneni, K., Bhamidipati, R., Shackleford, D. M., Angulo Barturen, I., Ferrer, S. B., Jiménez- Díaz, M. B., Gamo, F. J., Goldsmith, E. J., Charman,W. N., Bathurst, I., Floyd, D., Matthews, D., Burrows, J. N., Rathod, P. K., Charman, S. A. and Phillips, M. A. (2011). Structureguided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidatepotential. Journal of Medicinal Chemistry 54, 5540-5561
13. Dahl, E. L. and Rosenthal, P. J. (2007). Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrobial Agents and Chemotherapy 51, 3485-3490
14. Delves, M., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E. and Leroy, D. (2012). The activities of current antimalarial drugs on the life cycle stages of Plasmodium: A comparative study with human and rodent parasites. PLoS Medicine 9, e1001169
15. Dembele, L., Gego, A., Zeeman, A. M., Franetich, J. F., Silvie, O., Rametti, A., Le, G. R., Dereuddre-Bosquet, N., Sauerwein, R., van Gemert, G. J., Vaillant, J. C., Thomas, A.W., Snounou, G., Kocken, C. H. and Mazier, D. (2011). Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS ONE 6, e18162
16. Ding, X. C., Ubben, D. and Wells, T. N. (2012). A framework for assessing the risk of resistance for anti-malarials in development. Malaria Journal 11, 292
17. Duffy, S. and Avery, V. M. (2012). Development and optimisation of a novel 384-well anti-malarial imaging assay validated for highthroughput screening. American Journal of Tropical Medicine and Hygiene 86, 84-92
18. Duparc, S., Lanza, C., Ubben, D., Borghini-Fuhrer, I. and Kellam, L. (2012). Optimal dose finding for novel antimalarial combination therapy. Tropical Medicine and International Health 17, 409-413
19. Gamo, F. J., Sanz, L. M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J. L., Vanderwall, D. E., Green, D. V., Kumar, V., Hasan, S., Brown, J. R., Peishoff, C. E., Cardon, L. R. and Garcia-Bustos, J. F. (2010). Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305-310
20. Guiguemde,W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., Jimenez-Diaz, M. B., Martinez, M. S., Wilson, E. B., Tripathi, A. K., Gut, J., Sharlow, E. R., Bathurst, I., El Mazouni, F., Fowble, J.W., Forquer, I., McGinley, P. L., Castro, S., Angulo-Barturen, I., Ferrer, S., Rosenthal, P. J., Derisi, J. L., Sullivan, D. J., Lazo, J. S., Roos, D. S., Riscoe, M. K., Phillips, M. A., Rathod, P. K., Van Voorhis, W. C., Avery, V. M. and Guy, R. K. (2010). Chemical genetics of Plasmodium falciparum. Nature 465, 311-315
21. Guiguemde, W. A., Shelat, A. A., Garcia-Bustos, J. F., Diagana, T., Gamo, F. J. and Guy, R. K. (2012). Global phenotypic screening for antimalarials. Chemistry and Biology 19, 116-129
22. Gujjar, R., Marwaha, A., El Mazouni, F., White, J., White, K. L., Creason, S., Shackleford, D. M., Baldwin, J., Charman, W. N., Buckner, F. S., Charman, S., Rathod, P. K. and Phillips, M. A. (2009). Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. Journal of Medicinal Chemistry 52, 1864-1872
23. Jimenez-Diaz, M. B., Mulet, T., Viera, S., Gomez, V., Garuti, H., Ibanez, J., Alvarez-Doval, A., Shultz, L. D., Martinez, A., Gargallo-Viola, D. and Angulo-Barturen, I. (2009). Improved murine model of malaria using Plasmodium falciparum competent strains and nonmyelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrobial Agents and Chemotherapy 53, 4533-4536
24. Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M., Wu, T., Barnes, S.W., Bopp, s. e., Borboa, R., Bright, A. T., Che, J., Cohen, S., Dharia, N. V., Gagaring, K., Gettayacamin, M., Gordon, P., Groessl, T., Kato, N., Lee, M. C., McNamara, C.W., Fidock, D. A., Nagle, A., Nam, T. G., Richmond, W., Roland, J., Rottmann, M., Zhou, B., Froissard, P., Glynne, R. J., Mazier, D., Sattabongkot, J., Schultz, P. G., Tuntland, T., Walker, J. R., Zhou, Y., Chatterjee, A., Diagana, T. T. and Winzeler, E. A. (2011). Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science 334, 1372-1377
25. Möhrle, J., Duparc, S., Siethoff, C., van Giersbergen, P. L. M., Craft, J. C., Arbe-Barnes, S., Charman, S. A., Gutierrez, M., Wittlin, S. and Vennerstrom, J. L. (2012). First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials. British Journal of Clinical Pharmacology 75, 524-537
26. Nagle, A., Wu, T., Kuhen, K., Gagaring, K., Borboa, R., Francek, C., Chen, Z., Plouffe, D., Lin, X., Caldwell, C., Ek, J., Skolnik, S., Liu, F., Wang, J., Chang, J., Li, C., Liu, B., Hollenbeck, T., Tuntland, T., Isbell, J., Chuan, T., Alper, P. B., Fischli, C., Brun, R., Lakshminarayana, S. B., Rottmann, M., Diagana, T., Winzeler, E. A., Glynne, R., Tully, D. C. and Chatterjeee, A. K. (2012). Imidazolopiperazines: Lead optimization of the second-generation antimalarial agents. Journal of Medicinal Chemistry 55, 4244-4273
27. Noedl, H., Se, Y., Schaecher, K., Smith, B. L., Socheat, D. and Fukuda, M. M. (2008). Evidence of artemisinin-resistant malaria in western Cambodia. New England Journal of Medicine 359, 2619-2620
28. Payne, D. J., Gwynn, M. N., Holmes, D. J. and Pompliano, D. L. (2007). Drugs for bad bugs: Confronting the challenges of antibacterial discovery. Nature Reviews Drug Discovery 6, 29-40
29. Phyo, A. P., Nkhoma, S., Stepniewska, K., Ashley, E. A., Nair, S., McGready, R., Ler, M. C., Al-Saai, S., Dondorp, A. M., Lwin, K. M., Singhasivanon, P., Day, N. P., White, N. J., Anderson, T. J. and Nosten, F. (2012). Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study. Lancet 379, 1960-1966
30. Plouffe, D., Brinker, A., McNamara, C., Henson, K., Kato, N., Kuhen, K., Nagle, A., Adrian, F., Matzen, J. T., Anderson, P., Nam, T-g., Gray, N. S., Chatterjee, A., Janes, J., Yan, S. F., Trager, R., Caldwell, J. S., Schultz, P. G., Zhou, Y. and Winzeler, E. A. (2008). In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-Throughput screen. Proceedings of the National Academy of Sciences, USA 105, 9059-9064
31. Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J. and Anstey, N. M. (2007). Vivax malaria: Neglected and not benign. American Journal of Tropical Medicine and Hygiene 77(6 Suppl), 79-87
32. Rieckmann, K. H., McNamara, J. V., Frischer, H., Stockert, T. A., Carson, P. E. and Powell, R. D. (1968). Gametocytocidal and sporontocidal effectsof primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. Bulletin of the World Health Organisation 38, 625-632
33. Roll Back Malaria: RBM Annual Report 2011 (2012). http://www. rollbackmalaria.org/
34. Rottmann, M., McNamara, C., Yeung, B. K., Lee, M. C., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., Cohen, S. B., Spencer, K. R., Gonzalez-Paez, G. E., Lakshminarayana, S. B., Goh, A., Suwanarusk, R., Jegla, T., Schmitt, E. K., Beck, H. P., Brun, R., Nosten, F., Renia, L., Dartois, V., Keller, T. H., Fidock, D. A., Winzeler, E. A. and Diagana, T. (2010). Spiroindolones, a potent compound class for the treatment of malaria. Science 329, 1175-1180
35. Sanchez, B. A., Mota, M. M., Sultan, A. A. and Carvalho, L.H. (2004). Plasmodium berghei parasite transformed with green fluorescent protein for screening blood schizontocidal agents. International Journal for Parasitology 34, 485-490
36. Sanz, L. M., Crespo, B., De-Cozar, C., Ding, X. C., Llergo, J. L., Burrows, J. N., Garcia-Bustos, J. F. and Gamo, F. J. (2012). P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-Action. PLOS ONE 7, e30949
37. Sanz, L. M., Jimenez-Díaz, M. B., Crespo, B., De-Cozar, C., Almela, M. J., Angulo-Barturen, I., Castaneda, P., Ibanez, J., Fernandez, E. P., Ferrer, S., Herreros, E., Lozano, S., Martínez, M. S., Rueda, L., Burrows, J. N., García-Bustos, J. F. and Gamo, F. J. (2011). Cyclopropylcarboxamides, a chemically novel class of antimalarial agents identified in a phenotypic screen. Antimicrobial Agents and Chemotherapy 55, 5740-5745
38. Sinden, R. E. (2009). Malaria, sexual development and transmission: Retrospect and prospect. Parasitology 136, 1427-1434
39. Sinden, R. E., Carter, R., Drakeley, C. and Leroy, D. (2012a). The biology of sexual development of Plasmodium: The design and implementation of transmission-blocking strategies. Malaria Journal 11, 70
40. Sinden, R. E., Delves, M. J. and Blagborough, A. M. (2012b). Targeting the parasite in the mosquito: Rationale and practicality. Malaria Journal 11(Suppl 1), O5
41. Spangenberg, T., Burrows, J. N., Kowalczyk, P., McDonald, S., Wells, T. N. C. and Willis, P. (2013). The open access malaria box: A drug discovery catalyst for neglected diseases. PLoS ONE, in press
42. The malERA Consultative Group on Drugs. (2011). A research agenda for malaria eradication: Drugs. PLoS Medicine 8, e1000402
43. Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., McIntosh, K., Padmanilayam, M., Santo, T. J., Scheurer, C., Scorneaux, B., Tang, Y., Urwyler, H., Wittlin, S. and Charman, W. N. (2004). Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430, 900-904
44. Wells, T. N. C., Burrows, J. N. and Baird, J. K. (2010). Targeting the hypnozoite reservoir of Plasmodium vivax: The hidden obstacle to malaria elimination. Trends in Parasitology 26, 145-151
45. White, M. T., Conteh, L., Cibulskis, R. and Ghani, A. C. (2011). Costs and cost-effectiveness of malaria control interventions-A systematic review. Malaria Journal 10, 337
46. WHO (2010). Guidelines for the Treatment of Malaria, 2nd Edn. Geneva, Switzerland. ISBN 978 92 4 154792.4
47. WHO (2011). WHO World Malaria Report 2011. Geneva, Switzerland
48. WHO (2012a). WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva, Switzerland
49. WHO (2012b). WHO Policy Recommendation: Single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria. Geneva, Switzerland
50. Yeung, B. K., Zou, B., Rottmann, M., Lakshminarayana, S. B., Ang, S. H., Leong, S. Y., Tan, J., Wong, J., Keller-Maerki, S., Fischli, C., Goh, A., Schmitt, E. K., Krastel, P., Francotte, E., Kuhen, K., Plouffe, D., Henson, K., Wagner, T., Winzeler, E. A., Petersen, F., Brun, R., Dartois, V., Diagana, T. and Keller, T. H. (2010). Spirotetrahydrobetacarbolines (spiroindolones): A new class of potent and orally efficacious compounds for the treatment of malaria. Journal of Medicinal Chemistry 53, 5155-5164
51. Yuthavong, Y., Tarnchompoo, B., Vilaivan, T., Chitnumsub, P., Kamchonwongpaisan, S., Charman, S. A., McLennan, D. N., White, K. L., Vivas, L., Bongard, E., Thongphanchang, C., Taweechai, S., Vanichtanankul, J., Rattanajak, R., Arwon, U., Fantauzzi, P., Yuvaniyama, J., Charman, W. N. and Matthews, D. (2012). Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proceedings of the National Academy of Sciences, USA 109, 16823-1682